Neoeriocitrin

SKU: orb1297542

Description

Neoeriocitrin

Research Area

Neuroscience

Key Properties

• CAS Number: 13241-32-2
• MW: 596.53
• Purity: 99.93% (May vary between batches)
• Formula: C₂₇H₃₂O₁₅
• SMILES: O=C1C=2C(O[C@@H](C1)C3=CC(O)=C(O)C=C3)=CC(O[C@H]4[C@H](O[C@H]5[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O5)[C@@H](O)[C@H](O)[C@@H](CO)O4)=CC2O
• Target: Cholinesterase (ChE)
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.35 mM);DMSO:32.5 mg/mL (54.48 mM)

Bioactivity

• In Vitro:
  Both Neoeriocitrin and naringin exhibited the best effect on proliferation and osteogenic differentiation at concentration of 2μg/ml. Neoeriocitrin more significantly improved proliferation and alkaline phosphatase (ALP) activity as well as up-regulated Runx2, COLI and OCN expression by 56%, 37% and 14% respectively than naringin. Furthermore, Neoeriocitrin could rescue the inhibition effect of cell differentiation induced by PD98059 to some degree
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

phosphatase, MC3T3-E1, LDL, osteogenic, osteoporosis, Neoeriocitrin, PC12, Inhibitor, inhibit, AChE, alkaline, ?proliferation, differentiation, cell, Cholinesterase (ChE)

Compound Identifiers

PubChem CID

114627